Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 28, 2015 - Issue 13
Submit an article Journal homepage
2,363
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Placental lesions associated with acute atherosis

Yeon Mee KimDepartment of Pathology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea, Correspondence[email protected]
,
Piya ChaemsaithongPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA,
,
Roberto RomeroPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA, ;Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA, Correspondence[email protected]
,
Majid ShamanPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA,
,
Chong Jai KimPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea,
,
Jung-Sun KimPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Pathology, Samsung Medical Center, University of Sungkyunkwan School of Medicine, Seoul, Korea,
,
Faisal QureshiPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Pathology, Harper University Hospital, Detroit, MI, USA, and ;Department of Pathology, Wayne State University, Detroit, MI, USA
,
Suzanne M. JacquesPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Pathology, Harper University Hospital, Detroit, MI, USA, and ;Department of Pathology, Wayne State University, Detroit, MI, USA
,
Ahmed I. AhmedPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA,
,
Tinnakorn ChaiworapongsaPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA,
,
Sonia S. HassanPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA,
,
Lami YeoPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA,
&
Steven J. KorzeniewskiPerinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD and Detroit, MI, USA, ;Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA, ;Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA,
show all
Pages 1554-1562 | Received 30 Jul 2014, Accepted 29 Aug 2014, Published online: 30 Oct 2014

Abstract

Objective: Acute atherosis is a lesion of the spiral arteries characterized by fibrinoid necrosis of the vessel wall, an accumulation of fat-containing macrophages, and a mononuclear perivascular infiltrate, which can be found in patients with preeclampsia, fetal death, small-for-gestational age, spontaneous preterm labor/premature prelabor rupture of membrane, and spontaneous mid-trimester abortion. This lesion is thought to decrease blood flow to the intervillous space which may lead to other vascular lesions of the placenta. The objective of this study was to test whether there is an association between acute atherosis and placental lesions that are consistent with maternal vascular underperfusion (MVU), amniotic fluid infection (AFI), fetal vascular thrombo-occlusive disease (FVTOD) or chronic inflammation.

Material and methods: A retrospective cohort study of pregnant women who delivered between July 1998 and July 2014 at Hutzel Women’s Hospital/Detroit Medical Center was conducted examine 16 457 placentas. The frequency of placenta lesions (diagnosed using the criteria of the Perinatal Section of the Society for Pediatric Pathology) was compared between pregnancies with and without acute atherosis.

Results: Among 16 457 women who were enrolled, 10.2% (1671/16 457) were excluded, leaving 14 786 women who contributed data for analysis. Among them, the prevalence of acute atherosis was 2.2% (326/14 786). Women with acute atherosis were more than six times as likely as those without to have placental lesions consistent with maternal underperfusion (adjusted odds ratio – aOR: 6.7; 95% CI 5.2–8.6). To a lesser degree, acute atherosis was also associated with greater risks of having either lesions consistent with FVTOD (aOR 1.7; 95% CI 1.2–2.3) or chronic chorioamnionitis (aOR 1.9; 95% CI 1.3–3), but not with other chronic inflammatory lesions, after adjusting for gestational age at delivery. In contrast, women with acute atherosis were 60% less likely to have lesions consistent with AFI, adjusting for gestational age at delivery (aOR 0.4; 95% CI 0.3–0.5).

Conclusions: Acute atherosis is associated with increased risks of having placental lesions consistent with MVU, and to a lesser extent, chronic chorioamnionitis and those consistent with FVTOD.

Introduction

Acute atherosis is a vascular lesion characterized by fibrinoid necrosis of the vessel wall, an accumulation of fat-containing macrophages, and a mononuclear perivascular infiltrate [Citation1–50]. This lesion is usually identified in the spiral arteries which have not undergone physiologic transformation. Originally described in preeclampsia, acute atherosis has also been found in other complications of pregnancy including spontaneous preterm labor (sPTL)/premature prelabor rupture of membrane (PPROM) [Citation50], unexplained fetal death [Citation50], gestational diabetes mellitus [Citation5,Citation15,Citation24,Citation50], gestational and chronic hypertension [Citation15,Citation24,Citation27,Citation28,Citation50], systemic lupus erythematosus, and anti-phospholipid antibody syndrome [Citation14,Citation24,Citation31,Citation34,Citation37], intrauterine fetal growth restriction (IUGR) [Citation13,Citation16,Citation19,Citation20,Citation22,Citation32,Citation50]. It is rarely observed in normal pregnancy [Citation3,Citation4,Citation21,Citation30,Citation43,Citation50]. The presence of acute atherosis has also been associated with a more severe form of preeclampsia [Citation4,Citation46,Citation50].

Acute atherosis is considered to predispose to maternal vascular lesions of underperfusion (e.g. infarctions of the placenta) [Citation51] and is thought to represent “ischemic placental disease” [Citation52–55]. The relationship between acute atherosis and vascular lesions of the placenta, however, has not been rigorously examined. The objective of this study is to determine the associations among acute atherosis and histologic placental lesions consistent with maternal vascular underperfusion (MVU), fetal vascular thrombo-occlusive disease (FVTOD), chronic inflammation, or amniotic fluid infection (AFI).

Material and methods

This retrospective cohort study includes pregnant women who delivered between July 1998 and July 2014 at Hutzel Women’s Hospital/Detroit Medical Center and had pathologic examination of the placenta. All women provided written informed consent before specimen collection. The collection and utilization of the samples was approved by the Human Investigation Committee of Wayne State University and the IRB of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/DHHS). The clinical definitions, classification of pregnancy complications and sample collection have been described in a previous report [Citation50].

Placental pathology

Tissue samples obtained from each placenta; one roll of chorioamniotic membranes and one of the umbilical cord. Two sections were taken from each the chorionic and basal plate. Tissues were formalin-fixed and embedded in paraffin. Five-micrometer sections of tissue blocks were stained with hematoxylin and eosin (H&E) and the slides were examined by perinatal pathologists masked to clinical outcomes. Acute atherosis was diagnosed by the presence of fibrinoid necrosis of the spiral artery wall with the presence of lipid-laden macrophages in the lumen and a perivascular lymphocytic infiltrate [Citation28]. Histopathological changes of the placenta were defined according to diagnostic criteria proposed by the Perinatal Section of the Society for Pediatric Pathology [Citation51], which consists of three broad major categories: (1) lesions consistent with AFI; (2) MVU and; (3) FVTOD.

  1. Lesions associated with AFIs incorporate those that are consistent with a maternal response, including acute chorioamnionitis, and those that are consistent with a fetal response, including funisitis/acute chorion vasculitis. Acute chorioamnionitis is staged as follows: Stage 1 lesions include acute sub-chorionitis/acute chorionitis diagnosed when there are accumulations of neutrophils in the sub-chorionic zone and/or in the chorionic trophoblast layer of the extraplacental membranes; Stage 2 lesions are diagnosed when there are more than a few scattered neutrophils in the chorionic plate and membranous connective tissues and/or in the amnion; and Stage 3 lesions include necrotizing chorioamnionitis with a marked neutrophilic infiltrate with degenerating neutrophils (karyorrhexis), thickened eosinophilic amniotic basement membrane, and focal amnionic epithelial necrosis.

Funisitis is staged as follows: Stage 1 lesions include acute chorionic vasculitis/umbilical phlebitis, diagnosed when neutrophils are identified in the wall of any chorionic plate vessel or in the umbilical vein (a few neutrophils are usually present in Wharton’s jelly but without aggregates or concentric bands of inflammatory cells); Stage 2 funisitis is diagnosed when neutrophils are seen in one or both umbilical arteries and/or the umbilical vein; and Stage 3 funisitis, or necrotizing funisitis, is diagnosed when neutrophils, cellular debris, and/or mineralization is present in a concentric band, ring, or halo around one or more umbilical vessels.

  1. Lesions consistent with MVU are classified as: (1) villous changes, which are further sub-divided into abrupt onset (remote villous infarcts, recent villous infarcts), gradual onset with intermediate duration (increased syncytial knots, villous agglutination, increased intervillous fibrin) or gradual onset with prolonged duration (decreased placental weight/increased fetoplacental weight ratio, distal villous hypoplasia); and (2) vascular lesions (persistent muscularization of basal plate arteries, mural hypertrophy of decidual arterioles, acute atherosis of basal plate arteries and/or decidual arterioles). A change in the fetoplacental weight ratio criteria was not included in this study because the data were not available. Placental lesions consistent with maternal underperfusion were diagnosed if at least one pathologic lesion included in this category was present.

  2. Lesions consistent with FVTOD are also considered and are similarly classified as villous or vascular. Villous lesions of FVTOD are categorized as early, late or severe. Early villous lesions of FVTOD include villous stromal-vascular karyorrhexis (three or more foci of two or more terminal villi showing karyorrhexis of fetal cells with preservation of surrounding trophoblast). Late lesions of FVTOD consist of hyalinized avascular villi, either as exclusively small foci or variable sized foci, while severe lesions are consistent with fetal thrombotic vasculopathy with an average of 15 or more affected villi per slide.

Chronic placental inflammatory lesion diagnoses were recorded electronically for all women who enrolled in or beyond 2010. These include: (1) chronic chorioamnionitis; (2) villitis of unknown etiology and; (3) chronic deciduitis.

  1. Chronic chorioamnionitis is diagnosed when lymphocytic infiltration into the chorionic trophoblast layer or chorioamniotic connective tissue is observed [Citation56].The severity of chronic chorioamnionitis is scored based upon two parameters. The extent of inflammation is graded 0 when there is no inflammation, 1 when there is more than two foci or patchy inflammation, and 2 when diffuse inflammation is present. The stage of inflammation is scored as stage 1 if amniotropic lymphocytic infiltration is limited to the chorionic trophoblast layer sparing the chorioamniotic connective tissue, and stage 2 if lymphocytic infiltration into the chorioamniotic connective tissue is noted.

  2. Villitis of unknown etiology is defined as the presence of lymphohistiocytic infiltrate in varying proportion of the villous tree of placenta. When less than 10 villi are involved, the process is low grade and can be termed either focal (only one slide involved) or multi-focal (more than one slide involved). High-grade chronic villitis, has more than 10 villi per focus and separated into patchy and diffuse sub-groups with the latter sub-group being used when more than 5% of all distal villi are involved [Citation57,Citation58].

  3. Chronic deciduitis is defined as the presence of lymphocytic infiltration into the decidua of the basal plate. The assessments are subsequently assigned numerical scores for statistical calculations: 0 for absence, 1 for maybe, and 2 for presence. Three other features of the chronic inflammatory infiltrate, when present, are also scored by the pathologists: extent, scored as focal, multifocal, or diffuse (1, 2, or 3, respectively); severity, scored as mild, moderate or severe (1, 2, or 3), plasma cells, scored as absent or present (0 or 1) [Citation59].

Statistical analysis

The Kolmogorov–Smirnov test was used to assess the distributions of arithmetic data. The Kruskal–Wallis test for comparisons and the Mann–Whitney U test were used to make comparisons among and between groups for arithmetic variables. Chi-square or McNemar–Bowker tests were used for comparisons of categorical variables. Logistic regression models were fit to examine magnitudes of association, adjusting for gestational age at delivery. Statistical analysis was performed using SPSS 19 (IBM Corp, Armonk, NY) and SAS 9.3 (Cary, NC). A p value <0.05 was considered statistically significant.

Results

Among the 16 457 women who had enrolled and delivered at Hutzel Women’s Hospital between July 1998 and July 2014, 10.2% (1671/16 457) were excluded from this study because clinical information was incomplete, fetal anomalies, and multiple pregnancies, leaving 14 786 women who contributed data to this study. Among them, the prevalence of acute atherosis was 2.2% (326/14 786). Women with acute atherosis had a significantly higher median age, and greater frequencies of preeclampsia and fetal death, whereas the median birth weight and gestational age at delivery were significantly lower, when compared to women without acute atherosis (p < 0.001). On the other hand, sPTB/PPROM occurred more frequently in women without acute atherosis than in those with this lesion (p < 0.001; ).

Table 1. Demographic and clinical characteristics of the study population.

Placental lesions consistent with AFI, MVU (excluding acute atherosis of basal plate arteries and/or decidual arterioles), and fetal vascular thromboocclusive disease were identified in 28% (4122/14 715), 23.9% (3537/14 786), and 8.9% (1322/3386) of the study population, respectively. Among the sub-cohort enrolled since 2010, for whom the presence or absence of chronic inflammatory lesions was recorded, the prevalence of chronic chorioamnionitis, chronic deciduitis and villitis of unknown etiology was 26% (881/3386), 20.4% (692/3386) and 16.7% (564/3386), respectively ().

Table 2. The frequency of other placental lesions in women with and without acute atherosis.

Co-occurrence of acute atherosis with acute and chronic placental lesions

Placental findings consistent with MVU (excluding acute atherosis of basal plate arteries and/or decidual arterioles) and FVTOD were found more commonly among women with acute atherosis than in those without atherosis [70.9% (231/326) versus 22.9% (3306/14 460), p ≤ 0.0001; 14.4% (47/326) versus 8.8% (1275/14 460), p = 0.0005]. Among the sub-cohort with documented presence or absence of chronic inflammatory lesions, women with acute atherosis also had chronic inflammatory lesions more frequently than those who did not. [59.4% (57/96) versus 43.3% (1424/3290); p = 0.002]. In contrast, the frequency of placental lesions consistent with AFI was significantly lower in patients with acute atherosis than in those without [14.7% (48/326) versus 28.3% (4074/14 389); p < 0.0001] ().

Magnitudes of association among acute atherosis and other placental lesions

shows the odds of having placental lesions among women with acute atherosis compared to those without this lesion, adjusting for gestational age at delivery. Women with acute atherosis were more than six times as likely as those without to have placental lesions consistent with maternal underperfusion than (adjusted odds ratio – aOR: 6.7; 95% CI 5.2–8.6). To a lesser degree, acute atherosis was also associated with greater risks of having either lesions consistent with FVTOD (aOR 1.7; 95% CI 1.2–2.3) or chronic inflammatory lesions (aOR 2; 95% CI 1.3–3). The association between acute atherosis and chronic inflammatory lesions was driven primarily by an increased risk among women with chronic chorioamnionitis, since the other chronic lesions were no longer associated after adjusting for gestational age at delivery. In contrast, women with acute atherosis were 60% less likely to have lesions consistent with AFI, adjusting for gestational age at delivery (aOR 0.4; 95% CI 0.3–0.5).

Table 3. Odds of having placental lesion (any of each group) among women with acute atherosis relative to those without, adjusting for gestational age at delivery.

Discussion

Principal findings of this study

Acute atherosis is associated with an increased risk of having placental lesions consistent with MVU, and to a lesser extent, chronic chorioamnionitis and those consistent with FVTOD. By contrast, the odds of having lesions consistent with AFI were significantly lower in women with acute atherosis than in those without these lesions.

The association between acute atherosis and placental lesions consistent with maternal underperfusion

Maternal lesions of underperfusion are thought to mediate utero-placental ischemia, which has been proposed as a mechanism of disease in preeclampsia [Citation60–71], intrauterine growth restriction [Citation70,Citation72–76], fetal death [Citation77,Citation78] and abruptio placenta [Citation79,Citation80] (ischemic placental disease), preterm labor [Citation81–87], preterm prelabor rupture of membranes [Citation88,Citation89], recurrent spontaneous abortion [Citation17,Citation90] and massive perivillous fibrin deposition [Citation91–104]. It is important to clarify that the nosology of maternal vascular lesions consistent with underperfusion includes acute atherosis, and that we examined its association with other villous and vascular lesions consistent with MVU.

Acute atherosis and chronic chorioamnionitis

During the course of allograft rejection, vascular lesions can be detected in the transplanted organ and they are characterized by the presence of foam cells, intimal sclerosis and myointimal hyperplasia leading to a narrow vascular lumen [Citation105–111]. Typically, there is inflammatory cell infiltration (lymphocyte and macrophages) and extensive deposition of IgM, complement (C) 3 and C1q [Citation107,Citation112–116]. Immunohistochemistry studies have shown that IgM and C3 are detectable in decidual vessels with acute atherosis but not in spiral artery, which have undergone physiologic transformation [Citation15,Citation18,Citation20,Citation117–120]. Therefore, it is possible that in a subset of cases, acute atherosis represents the morphologic expression of maternal anti-fetal rejection [Citation26].

Chronic chorioamnionitis, the most common placental lesion in late spontaneous preterm birth [Citation121], is characterized by maternal T cells infiltration of the chorion laeve, which can cause trophoblast apoptosis. This chronic placental lesion resembles allograft rejection [Citation56]. We have previously reported that chronic chorioamnionitis is associated with anti-fetal HLA maternal sensitization [Citation122] and complement deposition in umbilical vein endothelium [Citation123], and this has been associated with a novel form of fetal systemic inflammation characterized by overexpression of T cell chemokines, such as CXCL-10 [Citation121].

Parallels between acute atherosis and the atheromatous lesions of atherosclerosis have been proposed [Citation47–49,Citation124]. Although both of these lesions are generally considered to reflect activation of the innate immune response (macrophages), there is accumulating evidence suggesting participation of the adaptive limb of the immune response as well [Citation125–137]. Specifically, T lymphocytes have been detected in the early stages of atheroma formation and they persist as the lesions grow and eventually rupture [Citation138]. Moreover, there is differential expression of three interferon gamma inducible CXC chemokines in atheromatous lesions, including: IFN-inducible protein 10 (CXCL10 or IP-10), monokine induced by IFN-y (CXCL9 or Mig), and IFN-inducible T-cell α chemoattractant (CXCL11 or I-TAC) [Citation138]. Mothers with chronic placental inflammation have higher concentrations of CXCL9, CXCL10 and CXCL11 than those without this lesion [Citation56], and we have also demonstrated changes in the behavior of circulating T cells [Citation139]. Therefore, it is tempting to hypothesize that circulating maternal T cells may participate in the genesis of acute atherosis. Further studies are required to test this hypothesis.

Acute atherosis and fetal thrombo-occlusive disease

The association between acute atherosis and fetal thrombo-occlusive diseases is novel. Preeclampsia [Citation140–149], preterm labor [Citation150–155], and fetal death [Citation156–162] were associated with thrombophilia. Inherited or acquired thrombophilic states have been implicated in the genesis of fetal thrombo-occlusive disease [Citation40,Citation163–168]. It is possible that a maternal thrombophilic state predisposes to acute atherosis and if the condition is inherited by the fetus, to thrombotic lesions in the fetal circulation. The role of acquired excessive thrombin generation in acute atherosis and fetal thrombo-occlusive disease requires further investigation.

Acute atherosis and amniotic fluid infection

Accumulating evidence demonstrated that term parturition was associated with intra-amniotic infection and/or inflammation [Citation169–182]. Patients with acute atherosis were less likely to have placental lesions consistent with AFI. The most probable explanation for this is that acute atherosis is most frequently observed in patients with preeclampsia and intrauterine growth restriction, which are frequent indications of cesarean delivery without labor; therefore, the lower frequency of placental lesions consistent with AFI might reflect that that patients without these lesions are more likely to undergo labor, which is associated with the occurrence of placental lesions consistent with AFI [Citation178,Citation183].

Strengths and limitations

Limitations of the study are those inherent in retrospective observational studies. We have previously reported the frequency of acute atherosis in a large number of placentas using standard techniques employed by clinical pathologists in the United States (two sections of the basal plate, stained with H&E, and without the use of immunohistochemistry techniques to identify macrophages, lipids, smooth muscle and interstitial trophoblast). A wider sampling of the basal plate of the placenta, examination of a larger number of spiral arteries, and the use of special staining may yield insight into the frequency of acute atherosis and associated placental lesions.

Conclusion

Acute atherosis is associated with increased risks of having placental lesions consistent with MVU, and to a lesser extent, chronic chorioamnionitis and those consistent with FVTOD.

Declaration of interests

This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HHSN275201300006C. The authors declare no declaration of interest.

References

  • Hertig AT. Vascular pathology in the hypertensive albuminuric toxemias of pregnancy. Clinics 1945;4:602–14
  • Sexton LI, Hertig AT, Reid DE, et al. Premature separation of the normally implanted placenta; a clinicopathological study of 476 cases. Am J Obstet Gynecol 1950;59:13–24
  • Zeek PM, Assali NS. Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy. Am J Clin Pathol 1950;20:1099–109
  • Maqueo M, Chavezazuela J, Dosaldelavega M. Placental pathology in eclampsia and preeclampsia. Obstet Gynecol 1964;24:350–56
  • Driscoll SG. The pathology of pregnancy complicated by diabetes mellitus. Med Clin North Am 1965;49:1053–67
  • Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 1967;93:581–92
  • Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972;1:177–91
  • Brosens I, Renaer M. On the pathogenesis of placental infarcts in pre-eclampsia. J Obstet Gynaecol Br Commonw 1972;79:794–99
  • Emmrich P, Birke R, Godel E. Morphology of myometrial and decidual arteries in normal pregnancy, in toxemia of pregnancy, and in maternal diabetes (author's transl). Pathol Microbiol (Basel) 1975;43:38–61
  • De Wolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975;123:164–74
  • Robertson WB, Brosens I, Dixon G. Uteroplacental vascular pathology. Eur J Obstet Gynecol Reprod Biol 1975;5:47–65
  • Robertson WB, Brosens I, Dixon G. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens 1976;5:115–27
  • De Wolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980;87:678–85
  • Abramowsky CR, Vegas ME, Swinehart G, et al. Decidual vasculopathy of the placenta in lupus erythematosus. N Engl J Med 1980;303:668–72
  • Kitzmiller JL, Watt N, Driscoll SG. Decidual arteriopathy in hypertension and diabetes in pregnancy: immunofluorescent studies. Am J Obstet Gynecol 1981;141:773–79
  • Sheppard BL, Bonnar J. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 1981;88:695–705
  • De Wolf F, Carreras LO, Moerman P, et al. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982;142:829–34
  • Hustin J, Foidart JM, Lambotte R. Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence. Placenta 1983;4:489–98
  • Althabe O, Labarrere C, Telenta M. Maternal vascular lesions in placentae of small-for-gestational-age infants. Placenta 1985;6:265–76
  • Labarrere C, Alonso J, Manni J, et al. Immunohistochemical findings in acute atherosis associated with intrauterine growth retardation. Am J Reprod Immunol Microbiol 1985;7:149–55
  • Labarrere C, Althabe O. Chronic villitis of unknown etiology and maternal arterial lesions in preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 1985;20:1–11
  • Khong TY, De Wolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049–59
  • McFadyen IR, Price AB, Geirsson RT. The relation of birthweight to histological appearances in vessels of the placental bed. Br J Obstet Gynaecol 1986;93:476–81
  • Labarrere CA, Catoggio LJ, Mullen EG, et al. Placental lesions in maternal autoimmune diseases. Am J Reprod Immunol Microbiol 1986;12:78–86
  • Khong TY, Pearce JM, Robertson WB. Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesion. Am J Obstet Gynecol 1987;157:360–63
  • Labarrere CA. Acute atherosis. A histopathological hallmark of immune aggression? Placenta 1988;9:95–108
  • Frusca T, Morassi L, Pecorelli S, et al. Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight. Br J Obstet Gynaecol 1989;96:835–39
  • Khong TY. Acute atherosis in pregnancies complicated by hypertension, small-for-gestational-age infants, and diabetes mellitus. Arch Pathol Lab Med 1991;115:722–25
  • Meekins JW, Pijnenborg R, Hanssens M, et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994;101:669–74
  • Meekins JW, Pijnenborg R, Hanssens M, et al. Immunohistochemical detection of lipoprotein(a) in the wall of placental bed spiral arteries in normal and severe preeclamptic pregnancies. Placenta 1994;15:511–24
  • Salafia CM, Parke AL. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Rheum Dis Clin North Am 1997;23:85–97
  • Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977;84:656–63
  • Gerretsen G, Huisjes HJ, Elema JD. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 1981;88:876–81
  • Nayar R, Lage JM. Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature. Hum Pathol 1996;27:201–6
  • Hayati AR, Azizah A, Wahidah A. Incidence of acute atherosis in complete molar pregnancy. Malays J Pathol 1998;20:113–114
  • Khong TY, Hague WM. The placenta in maternal hyperhomocysteinaemia. Br J Obstet Gynaecol 1999;106:273–78
  • Ogishima D, Matsumoto T, Nakamura Y, et al. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol Int 2000;50:224–29
  • Sebire NJ, Rees H, Paradinas F, et al. Extravillus endovascular implantation site trophoblast invasion is abnormal in complete versus partial molar pregnancies. Placenta 2001;22:725–28
  • Moldenhauer JS, Stanek J, Warshak C, et al. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003;189:1173–77
  • Kraus FT, Redline RW, Gersell DJ, et al. Circulatory problems: thrombi and other vascular lesions. In: King DW, ed. Placental pathology, 1st ed. Washington DC: American Registry of Pathology; 2004:117–56
  • Faye-Petersen O, Heller DS, Joshi VV. Histologic lesions of the placenta: villi, fetal stem arteries, intervillous space and maternal arteries in decidua. In: Faye-Petersen O, Heller DS, Joshi VV, eds. Handbook of placental pathology, 2nd ed. United Kingdom: Taylor & Francis; 2006:53–78
  • Fox H, Sebire NJ. Histological abnormalities of the placenta. In: Fox H, Sebire NJ, eds. Pathology of the placenta, 3rd ed. China: Elsevier; 2007:147–86
  • Harsem NK, Roald B, Braekke K, et al. Acute atherosis in decidual tissue: not associated with systemic oxidative stress in preeclampsia. Placenta 2007;28:958–64
  • Brosens I, Khong TY. Defective spiral artery remodeling. In: Pijnenborg R, Brosens I, Romero R, eds. Placental bed disorders. Cambridge, UK: Cambridge University Press; 2010:11–21
  • Staff AC, Dechend R, Pijnenborg R. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension 2010;56:1026–34
  • Stevens DU, Al-Nasiry S, Bulten J, et al. Decidual vasculopathy in preeclampsia: lesion characteristics relate to disease severity and perinatal outcome. Placenta 2013;34:805–9
  • Staff AC, Dechend R, Redman CW. Review: preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses. Placenta 2013;34:S73–78
  • Staff AC, Johnsen GM, Dechend R, et al. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol 2014;101–102:120–26
  • Staff AC, Redman CW. IFPA Award in Placentology Lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease. Placenta 2014;35:S26–31
  • Kim YM, Chaemsaithong P, Romero R, et al. The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small for gestational age, fetal death and mid-trimester spontaneous abortion. J Matern Fetal Neonatal Med (submitted). 2014. (in press)
  • Redline RW, Heller D, Keating S, et al. Placental diagnostic criteria and clinical correlation–a workshop report. Placenta 2005;26:S114–17
  • Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol 2006;195:1557–63
  • Ananth CV, Smulian JC, Vintzileos AM. Ischemic placental disease: maternal versus fetal clinical presentations by gestational age. J Matern Fetal Neonatal Med 2010;23:887–93
  • Ananth CV, Vintzileos AM. Ischemic placental disease: epidemiology and risk factors. Eur J Obstet Gynecol Reprod Biol 2011;159:77–82
  • Ananth CV. Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption. Semin Perinatol 2014;38:131–2
  • Kim CJ, Romero R, Kusanovic JP, et al. The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Modern Pathol 2010;23:1000–11
  • Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007;38:1439–46
  • Kim MJ, Romero R, Kim CJ, et al. Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J Immunol 2009;182:3919–27
  • Khong TY, Bendon RW, Qureshi F, et al. Chronic deciduitis in the placental basal plate: definition and interobserver reliability. Hum Pathol 2000;31:292–95
  • Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008;61:1254–60
  • Pijnenborg R, Brosens I. Deep trophoblast invasion and spiral artery remodeling. In: Pijnenborg R, Brosens I, Romero R, eds. Placental bed disorders. Cambridge: Cambridge University Press; 2010:97–108
  • Ogge G, Chaiworapongsa T, Romero R, et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011;39:641–52
  • Pathak S, Lees CC, Hackett G, et al. Frequency and clinical significance of placental histological lesions in an unselected population at or near term. Virchows Arch 2011;459:565–72
  • Brosens I, Pijnenborg R, Vercruysse L, et al. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol 2011;204:193–201
  • Khong Y, Brosens I. Defective deep placentation. Best Pract Res Clin Obstet Gynaecol 2011;25:301–11
  • Pijnenborg R, Vercruysse L, Brosens I. Deep placentation. Best Pract Res Clin Obstet Gynaecol 2011;25:273–85
  • Soto E, Romero R, Kusanovic JP, et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med 2012;25:498–507
  • Kovo M, Schreiber L, Ben-Haroush A, et al. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction. Prenat Diagn 2012;32:632–37
  • Stark MW, Clark L, Craver RD. Histologic differences in placentas of preeclamptic/eclamptic gestations by birthweight, placental weight, and time of onset. Pediatr Dev Pathol 2014;17:181–9
  • Kovo M, Schreiber L, Bar J. Placental vascular pathology as a mechanism of disease in pregnancy complications. Thromb Res 2013;131:S18–21
  • Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014;10:466–80
  • Aviram R, T BS, Kidron D. Placental aetiologies of foetal growth restriction: clinical and pathological differences. Early Hum Dev 2010;86:59–63
  • Spinillo A, Gardella B, Bariselli S, et al. Placental histopathological correlates of umbilical artery Doppler velocimetry in pregnancies complicated by fetal growth restriction. Prenat Diagn 2012;32:1263–72
  • Parra-Saavedra M, Crovetto F, Triunfo S, et al. Placental findings in late-onset SGA births without Doppler signs of placental insufficiency. Placenta 2013;34:1136–41
  • Triunfo S, Lobmaier S, Parra-Saavedra M, et al. Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion. Placenta 2014;35:398–403
  • Parra-Saavedra M, Crovetto F, Triunfo S, et al. Association of Doppler parameters with placental signs of underperfusion in late-onset SGA pregnancies. Ultrasound Obstet Gynecol 2014;44:330–7
  • Ball E, Bulmer JN, Ayis S, et al. Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol 2006;208:535–42
  • Kidron D, Bernheim J, Aviram R. Placental findings contributing to fetal death, a study of 120 stillbirths between 23 and 40 weeks gestation. Placenta 2009;30:700–4
  • Dommisse J, Tiltman AJ. Placental bed biopsies in placental abruption. Br J Obstet Gynaecol 1992;99:651–54
  • Ananth CV, Peltier MR, Kinzler WL, et al. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am J Obstet Gynecol 2007;197:273 e271–77
  • Arias F, Rodriquez L, Rayne SC, et al. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168:585–91
  • Kim YM, Bujold E, Chaiworapongsa T, et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003;189:1063–69
  • Romero R, Espinoza J, Kusanovic JP, et al. The preterm parturition syndrome. BJOG. 2006;113:17–42
  • Chaiworapongsa T, Romero R, Tarca A, et al. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med 2009;22:1122–39
  • Roescher AM, Hitzert MM, Timmer A, et al. Placental pathology is associated with illness severity in preterm infants in the first twenty-four hours after birth. Early Hum Dev 2011;87:315–19
  • Kovo M, Schreiber L, Ben-Haroush A, et al. The placental factor in spontaneous preterm labor with and without premature rupture of membranes. J Perinat Med 2011;39:423–29
  • Roescher AM, Timmer A, Hitzert MM, et al. Placental pathology and neurological morbidity in preterm infants during the first two weeks after birth. Early Hum Dev 2014;90:21–25
  • Kim YM, Chaiworapongsa T, Gomez R, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002;187:1137–42
  • Arias F, Victoria A, Cho K, et al. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997;89:265–71
  • Khong TY, Liddell HS, Robertson WB. Defective haemochorial placentation as a cause of miscarriage: a preliminary study. Br J Obstet Gynaecol 1987;94:649–55
  • Clewell WH, Manchester DK. Recurrent maternal floor infarction: a preventable cause of fetal death. Am J Obstet Gynecol 1983;147:346–47
  • Nickel RE. Maternal floor infarction: an unusual cause of intrauterine growth retardation. Am J Dis Child 1988;142:1270–71
  • Andres RL, Kuyper W, Resnik R, et al. The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol 1990;163:935–38
  • Gersell DJ. Chronic villitis, chronic chorioamnionitis, and maternal floor infarction. Semin Diagn Pathol 1993;10:251–66
  • Mandsager NT, Bendon R, Mostello D, et al. Maternal floor infarction of the placenta: prenatal diagnosis and clinical significance. Obstet Gynecol 1994;83:750–54
  • Bendon RW, Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med 1996;16:293–97
  • Katz J, Street A, Arias I. Individual differences in self-appraisals and responses to dating violence scenarios. Violence Vict 1997;12:265–76
  • Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 2002;5:159–64
  • Sebire NJ, Backos M, Goldin RD, et al. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG 2002;109:570–73
  • Bane AL, Gillan JE. Massive perivillous fibrinoid causing recurrent placental failure. BJOG 2003;110:292–95
  • Gupta N, Sebire NJ, Miskry T, et al. Massive perivillous fibrin deposition associated with discordant fetal growth in a dichorionic twin pregnancy. J Obstet Gynaecol 2004;24:579–80
  • Romero R, Whitten A, Korzeniewski SJ, et al. Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection? Am J Reprod Immunol 2013;70:285–98
  • Whitten AE, Romero R, Korzeniewski SJ, et al. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. Am J Obstet Gynecol 2013;208:310 e311–310 e311
  • Al-Sahan N, Grynspan D, von Dadelszen P, et al. Maternal floor infarction: management of an underrecognized pathology. J Obstet Gynaecol Res 2014;40:293–96
  • Dempster WJ, Harrison CV, Shackman R. Rejection processes in human homotransplanted kidneys. Br Med J 1964;2:969–76
  • Hess ML, Hastillo A, Mohanakumar T, et al. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia. Circulation 1983;68:II94–101
  • Palmer DC, Tsai CC, Roodman ST, et al. Heart graft arteriosclerosis. An ominous finding on endomyocardial biopsy. Transplantation 1985;39:385–88
  • Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 2007;100:967–78
  • Biedermann BC. Vascular endothelium and graft-versus-host disease. Best Pract Res Clin Haematol 2008;21:129–38
  • Mitchell RN. Graft vascular disease: immune response meets the vessel wall. Annu Rev Pathol 2009;4:19–47
  • Pareja E, Cortes M, Navarro R, et al. Vascular complications after orthotopic liver transplantation: hepatic artery thrombosis. Transplant Proc 2010;42:2970–72
  • Torzewski J, Bowyer DE, Waltenberger J, et al. Processes in atherogenesis: complement activation. Atherosclerosis 1997;132:131–8
  • Niculescu F, Rus H. The role of complement activation in atherosclerosis. Immunol Res 2004;30:73–80
  • Haskard DO, Boyle JJ, Mason JC. The role of complement in atherosclerosis. Curr Opin Lipidol 2008;19:478–82
  • Shields KJ, Stolz D, Watkins SC, et al. Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis. Clin Transl Sci 2011;4:146–52
  • Hertle E, van Greevenbroek MM, Arts IC, et al. Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease. The CODAM study. Thromb Haemost 2014;111:1102–11
  • Kitzmiller JL, Benirschke K. Immunofluorescent study of placental bed vessels in pre-eclampsia of pregnancy. Am J Obstet Gynecol 1973;115:248–51
  • Weir PE. Immunofluorescent studies of the uteroplacental arteries in normal pregnancy. Br J Obstet Gynaecol 1981;88:301–7
  • Labarrere CA, Althabe OH. Primary chronic abortion, preeclampsia, idiopathic intrauterine growth retardation, hydatidiform mole, and choriocarcinoma: a unifying concept. Am J Reprod Immunol Microbiol 1986;10:156–57
  • Bulmer JN. Immune aspects of pathology of the placental bed contributing to pregnancy pathology. Baillieres Clin Obstet Gynaecol 1992;6:461–88
  • Lee J, Kim JS, Park JW, et al. Chronic chorioamnionitis is the most common placental lesion in late preterm birth. Placenta 2013;34:681–89
  • Lee J, Romero R, Xu Y, et al. Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol 2011;66:510–26
  • Lee J, Romero R, Xu Y, et al. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS One 2011;6:e16806
  • Katabuchi H, Yih S, Ohba T, et al. Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells. Med Electron Microsc 2003;36:253–62
  • Libby P. Inflammation in atherosclerosis. Nature 2002;420:868–74
  • Libby P. Atherosclerosis: disease biology affecting the coronary vasculature. Am J Cardiol 2006;98:3Q–9Q
  • Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009;6:399–409
  • Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129–38
  • Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009;27:165–97
  • Packard RR, Lichtman AH, Libby P. Innate and adaptive immunity in atherosclerosis. Semin Immunopathol 2009;31:5–22
  • Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis. Clin Immunol 2010;134:33–46
  • Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473:317–25
  • Legein B, Temmerman L, Biessen EA, et al. Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci 2013;70:3847–69
  • Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013;38:1092–104
  • Rosenfeld ME. Inflammation and atherosclerosis: direct versus indirect mechanisms. Curr Opin Pharmacol 2013;13:154–60
  • Woollard KJ. Immunological aspects of atherosclerosis. Clin Sci (Lond) 2013;125:221–35
  • Ait-Oufella H, Sage AP, Mallat Z, et al. Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis. Circ Res 2014;114:1640–60
  • Mach F, Sauty A, Iarossi AS, et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999;104:1041–50
  • Xu Y, Tarquini F, Romero R, et al. Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis. Am J Reprod Immunol 2012;67:184–97
  • Salafia CM, Pezzullo JC, Lopez-Zeno JA, et al. Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol 1995;173:1097–105
  • Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9–13
  • Chaiworapongsa T, Yoshimatsu J, Espinoza J, et al. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med 2002;11:362–67
  • Agorastos T, Karavida A, Lambropoulos A, et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med 2002;12:267–73
  • Brenner B, Kupferminc MJ. Inherited thrombophilia and poor pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2003;17:427–39
  • Kupferminc JM. Management of thrombophilia in women with PVC. Thromb Res 2005;115:46–50
  • Erez O, Hoppensteadt D, Romero R, et al. Preeclampsia is associated with low concentrations of protein Z. J Matern Fetal Neonatal Med 2007;20:661–67
  • Erez O, Romero R, Kim SS, et al. Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation. J Matern Fetal Neonatal Med 2008;21:345–55
  • Kupferminc MJ, Rimon E, Many A, et al. Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications. J Matern Fetal Neonatal Med 2011;24:1042–45
  • Conserva V, Muggiasca M, Arrigoni L, et al. Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study. J Matern Fetal Neonatal Med 2012;25:1467–73
  • Kusanovic JP, Espinoza J, Romero R, et al. Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor. J Matern Fetal Neonatal Med 2007;20:453–63
  • Erez O, Romer R, Vaisbuch E, et al. Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation. J Matern Fetal Neonatal Med 2009;22:971–82
  • Kramer MS, Kahn SR, Rozen R, et al. Vasculopathic and thrombophilic risk factors for spontaneous preterm birth. Int J Epidemiol 2009;38:715–23
  • Erez O, Espinoza J, Chaiworapongsa T, et al. A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor. J Matern Fetal Neonatal Med 2008;21:732–44
  • Gargano JW, Holzman CB, Senagore PK, et al. Polymorphisms in thrombophilia and renin-angiotensin system pathways, preterm delivery, and evidence of placental hemorrhage. Am J Obstet Gynecol 2009;201:317 e311–19
  • Erez O, Romero R, Vaisbuch E, et al. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor. J Matern Fetal Neonatal Med 2010;23:23–33
  • Alonso A, Soto I, Urgelles MF, et al. Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol 2002;187:1337–42
  • Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171–96
  • Erez O, Gotsch F, Mazaki-Tovi S, et al. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. J Matern Fetal Neonatal Med 2009;22:672–87
  • Benedetto C, Marozio L, Tavella AM, et al. Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann N Y Acad Sci 2010;1205:106–17
  • Kjellberg U, van Rooijen M, Bremme K, et al. Factor V Leiden mutation and pregnancy-related complications. Am J Obstet Gynecol 2010;203:469 e461–8
  • Werner EF, Lockwood CJ. Thrombophilias and stillbirth. Clin Obstet Gynecol 2010;53:617–27
  • Aracic N, Roje D, Drmic Hofman I, et al. Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome. J Matern Fetal Neonatal Med 2014;22:1–5. [Epub ahead of print]
  • Arias F, Romero R, Joist H, et al. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998;7:277–86
  • Vern TZ, Alles AJ, Kowal-Vern A, et al. Frequency of factor V(Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions. Hum Pathol 2000;31:1036–43
  • Ariel I, Anteby E, Hamani Y, et al. Placental pathology in fetal thrombophilia. Hum Pathol 2004;35:729–33
  • Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004;7:443–52
  • Saleemuddin A, Tantbirojn P, Sirois K, et al. Obstetric and perinatal complications in placentas with fetal thrombotic vasculopathy. Pediatr Dev Pathol 2010;13:459–64
  • Lepais L, Gaillot-Durand L, Boutitie F, et al. Fetal thrombotic vasculopathy is associated with thromboembolic events and adverse perinatal outcome but not with neurologic complications: a retrospective cohort study of 54 cases with a 3-year follow-up of children. Placenta 2014;35:611–17
  • Fox H, Langley FA. Leukocytic infiltration of the placenta and umbilical cord. A clinico-pathologic study. Obstet Gynecol 1971;37:451–58
  • Dong Y, St Clair PJ, Ramzy I, et al. A microbiologic and clinical study of placental inflammation at term. Obstet Gynecol 1987;70:175–82
  • Moller GH, Woods DL, Malan AF, et al. Chorio-amnionitis in relation to mode of delivery at term. S Afr Med J 1989;76:201–2
  • Nordenvall M, Sandstedt B. Chorioamnionitis in relation to gestational outcome in a Swedish population. Eur J Obstet Gynecol Reprod Biol 1990;36:59–67
  • Halgunset J, Johnsen H, Kjollesdal AM, et al. Cytokine levels in amniotic fluid and inflammatory changes in the placenta from normal deliveries at term. Eur J Obstet Gynecol Reprod Biol 1994;56:153–60
  • Keski-Nisula L, Aalto ML, Katila ML, et al. Intrauterine inflammation at term: a histopathologic study. Hum Pathol 2000;31:841–46
  • Hebisch G, Grauaug AA, Neumaier-Wagner PM, et al. The relationship between cervical dilatation, interleukin-6 and interleukin-8 during term labor. Acta Obstet Gynecol Scand 2001;80:840–48
  • Lee SE, Romero R, Kim CJ, et al. Funisitis in term pregnancy is associated with microbial invasion of the amniotic cavity and intra-amniotic inflammation. J Matern Fetal Neonatal Med 2006;19:693–97
  • Chaiworapongsa T, Erez O, Kusanovic JP, et al. Amniotic fluid heat shock protein 70 concentration in histologic chorioamnionitis, term and preterm parturition. J Matern Fetal Neonatal Med 2008;21:449–61
  • Seong HS, Lee SE, Kang JH, et al. The frequency of microbial invasion of the amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the presence or absence of labor. Am J Obstet Gynecol 2008;199:375 e371–75
  • Gotsch F, Romero R, Kusanovic JP, et al. The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008;21:529–47
  • Hamill N, Romero R, Gotsch F, et al. Exodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection. J Perinat Med 2008;36:217–27
  • Gotsch F, Romero R, Chaiworapongsa T, et al. Evidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturition. J Matern Fetal Neonatal Med 2008;21:605–16
  • Lee SM, Romero R, Lee KA, et al. The frequency and risk factors of funisitis and histologic chorioamnionitis in pregnant women at term who delivered after the spontaneous onset of labor. J Matern Fetal Neonatal Med 2011;24:37–42
  • Lee SM, Lee KA, Kim SM, et al. The risk of intra-amniotic infection, inflammation and histologic chorioamnionitis in term pregnant women with intact membranes and labor. Placenta 2011;32:516–21

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.